1. Kang, Eunji, Kim, Kanggeon, Jeon, Sook Young, Lee, Han-Byoel, Han, Wonshik. 2022. Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway. In Cancer gene therapy, 29, 1168-1180. doi:10.1038/s41417-021-00419-0. https://pubmed.ncbi.nlm.nih.gov/35046528/
2. Shen, Yaxing, Zhang, Heng, Yao, Shihua, He, Jie, Zhang, Zhiyong. . Methionine oxidation of CLK4 promotes the metabolic switch and redox homeostasis in esophageal carcinoma via inhibiting MITF selective autophagy. In Clinical and translational medicine, 12, e719. doi:10.1002/ctm2.719. https://pubmed.ncbi.nlm.nih.gov/35092699/
3. Mucka, Patrick, Lindemann, Peter, Bosco, Bartolomeo, Nazaré, Marc, Scheidereit, Claus. 2023. CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors. In Cell chemical biology, 30, 1303-1312.e3. doi:10.1016/j.chembiol.2023.06.027. https://pubmed.ncbi.nlm.nih.gov/37506701/
4. Huang, Jian, Wang, Luxin, Shen, Yunli, Zhang, Qi, Chen, Yi-Han. 2022. CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation. In Nature communications, 13, 4433. doi:10.1038/s41467-022-31996-9. https://pubmed.ncbi.nlm.nih.gov/35907876/
5. Fei, Chen-Jie, Li, Ze-Yu, Ning, Jing, Yu, Jin-Tai, Cheng, Wei. 2024. Exome sequencing identifies genes associated with sleep-related traits. In Nature human behaviour, 8, 576-589. doi:10.1038/s41562-023-01785-5. https://pubmed.ncbi.nlm.nih.gov/38177695/
智鼠故事 
